Skip to main content
Friday, October 30, 2026Oct 30

The Associated Press


Trump increased investments in drugmakers that benefited from Medicare exemptions, Democrats say

Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations, according to a report from congressional Democrats.

President Donald Trump speaks in the Rose Garden of the White House during an event for first responders, Thursday, Oct. 15, 2026, in Washington. (AP Photo/Julia Demaree Nikhinson)